{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:12:15Z","timestamp":1782299535680,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1007\/s005990070017","type":"journal-article","created":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T01:54:09Z","timestamp":1045101249000},"page":"67-73","source":"Crossref","is-referenced-by-count":34,"title":["Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus"],"prefix":"10.1007","volume":"30","author":[{"given":"F.","family":"Dammacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Della Casa Alberighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferraccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Casatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"302067_CR1","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM199406303302608","volume":"26","author":"JA Mills","year":"1994","unstructured":"Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 26:1871.","journal-title":"N Engl J Med"},{"key":"302067_CR2","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.1990.03440130100033","volume":"263","author":"JH Klippel","year":"1990","unstructured":"Klippel JH. Systemic lupus erythematosus: treatment related complications superimposed on chronic disease. JAMA 1990; 263:1812.","journal-title":"JAMA"},{"key":"302067_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00002281-199509000-00007","volume":"7","author":"DD Gladman","year":"1995","unstructured":"Gladman DD. Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1995; 7:402.","journal-title":"Curr Opin Rheumatol"},{"key":"302067_CR4","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.81.16.5214","volume":"81","author":"M Krone","year":"1984","unstructured":"Krone M, Leonard WJ, Dopper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Green WC. Cyclosporin A inhibits T cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984; 81:5214.","journal-title":"Proc Natl Acad Sci USA"},{"key":"302067_CR5","first-page":"5","volume-title":"Cyclosporine A","author":"JF Borel","year":"1982","unstructured":"Borel JF. The history of cyclosporine A and its significance. In: White DJG, ed. Cyclosporine A. Amsterdam: Elsevier; 1982:5\u201317."},{"key":"302067_CR6","first-page":"3077","volume-title":"Cyclosporine: the ten-year experience","author":"JF Bach","year":"1994","unstructured":"Bach JF. Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases. In: Kahan BD, ed. Cyclosporine: the ten-year experience. Norwalk: Appleton and Lange; 1994:3077\u20133081."},{"key":"302067_CR7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/art.1780351116","volume":"35","author":"M Blank","year":"1992","unstructured":"Blank M, Ben-Bassat M, Shoenfeld Y. The effect of cyclosporin A on early and late stages of experimental lupus. Arthritis Rheum 1992; 35:1350.","journal-title":"Arthritis Rheum"},{"key":"302067_CR8","first-page":"295","volume":"16","author":"PA Miescher","year":"1994","unstructured":"Miescher PA, Favre H, Lemoine R, Huang YP. Drug combination therapy of systemic lupus erythematosus. Springer Semin Immunopathol 1994; 16:295.","journal-title":"Springer Semin Immunopathol"},{"key":"302067_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3476(87)80057-4","volume":"III","author":"G Feutren","year":"1987","unstructured":"Feutren G, Querin S, No\u00ebl LH, Chatenoud L, Beaurain G, Tron F, Lesavre P, Bach JF. Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 1987; III:1063.","journal-title":"J Pediatr"},{"key":"302067_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780370416","volume":"37","author":"M Tokuda","year":"1994","unstructured":"Tokuda M, Kurata N, Mizoguchi AJ, Inoh M, Seto K, Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythematosus. Arthritis Rheum 1994; 37:551.","journal-title":"Arthritis Rheum"},{"key":"302067_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/35.7.669","volume":"35","author":"K Manger","year":"1996","unstructured":"Manger K, Kalden JR, Manger B. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 1996; 35:669.","journal-title":"Br J Rheumatol"},{"key":"302067_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.1780400106","volume":"40","author":"D Caccavo","year":"1997","unstructured":"Caccavo D, Lagan\u00e0 B, Mitterhofer AP, Ferri GM, Afeltra A, Amoroso A, Bonomo L. Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthrits Rheum 1997; 40:27.","journal-title":"Arthrits Rheum"},{"issue":"Suppl","key":"302067_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000168040","volume":"9","author":"H Favre","year":"1989","unstructured":"Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch M. Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989; 9 [Suppl]:57.","journal-title":"Am J Nephrol"},{"key":"302067_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000421703","volume":"99","author":"M Balletta","year":"1992","unstructured":"Balletta M, Sabella D, Magri P, Sepe V, Stanziale P, Di Luccio R, Colucci G, Fuiano G. Cyclosporin plus steroids versus steroids alone in the treatment of lupus nephritis. Contrib Nephrol 1992; 99:129.","journal-title":"Contrib Nephrol"},{"key":"302067_CR15","first-page":"160","volume":"40","author":"MM Hussein","year":"1993","unstructured":"Hussein MM, Moo\u00ff JMV, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 1993; 40:160.","journal-title":"Clin Nephrol"},{"key":"302067_CR16","first-page":"147","volume":"42","author":"J Radhakrishnan","year":"1994","unstructured":"Radhakrishnan J, Kunis CL, D\u2019Agati V, Appel GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994; 42:147.","journal-title":"Clin Nephrol"},{"key":"302067_CR17","first-page":"1328","volume":"7","author":"HA Austin","year":"1996","unstructured":"Austin HA, Vaughan EM, Boumpas DT, Klippel JH, Balow JE. Lupus membranous nephropathy: controlled trial of prednisone, pulse cyclophosphamide, and cyclosporine A (abstract). Am Soc Nephrol 1996; 7:1328.","journal-title":"Am Soc Nephrol"},{"key":"302067_CR18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NF, Schaller JR, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.","journal-title":"Arthritis Rheum"},{"issue":"Suppl A","key":"302067_CR19","first-page":"193","volume":"5","author":"G Feutren","year":"1992","unstructured":"Feutren G. The optimal use of cyclosporin A in autoimmune diseases. J Autoimmun 1992; 5 [Suppl A]:193.","journal-title":"J Autoimmun"},{"key":"302067_CR20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/anr.1780320909","volume":"32","author":"MH Liang","year":"1989","unstructured":"Liang MH, Socher SA, Larson MG, Schur PM. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32:1107.","journal-title":"Arthritis Rheum"},{"key":"302067_CR21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"352","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 352:630.","journal-title":"Arthritis Rheum"},{"key":"302067_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockroft","year":"1976","unstructured":"Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31.","journal-title":"Nephron"},{"key":"302067_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0889-857X(21)00955-8","volume":"14","author":"RP Kimberly","year":"1988","unstructured":"Kimberly RP. Corticosteroids and anti-inflammatory drugs. Rheum Dis Clin North Am 1988; 14:203.","journal-title":"Rheum Dis Clin North Am"},{"key":"302067_CR24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJM198412133112402","volume":"311","author":"DT Felson","year":"1984","unstructured":"Felson DT, Anderson J. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. N Engl J Med 1984; 311:1528.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"302067_CR25","first-page":"1","volume":"23","author":"GS Panayi","year":"1993","unstructured":"Panayi GS, Tugwell P. An international consensus report: the use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993; 23 [Suppl 1]:1.","journal-title":"Br J Rheumatol"}],"container-title":["International Journal of Clinical & Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990070017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s005990070017\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990070017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:14:25Z","timestamp":1682284465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s005990070017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["302067"],"URL":"https:\/\/doi.org\/10.1007\/s005990070017","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}